RANDOX LABORATORIES LIMITED

Home/Brands/RANDOX LABORATORIES LIMITED

RANDOX LABORATORIES LIMITED

Main Filters

RANDOX LABORATORIES LIMITED

RANDOX LABORATORIES LIMITED
CATALOG #	QTY	PRICE	DESCRIPTION
CD7942	0	-	The device is intended for the quantitative in vitro determination of carbon dioxide in serum or plasma.
CE190	0	-
CE7944	0	-
CF1500	0	-	This product is intended for in vitro diagnostic use, in the quality control of diagnostic methods using CSF as a sample on clinical chemistry systems. The CSF controls are for the control of accuracy.
CF1501	0	-	This product is intended for in vitro diagnostic use, in the quality control of diagnostic methods using CSF as a sample on clinical chemistry systems. The CSF controls are for the control of accuracy.
CH200	0	-	For the quantitative in vitro determination of Cholesterol in serum and plasma.
CH203	0	-
CH2655	0	-	Enzymatic Clearance assay for the in vitro quantitative determination of HDL-cholesterol in human serum and plasma.
CH2673	0	-	The device is intended for in vitro diagnostic use in the calibration of Randox HDL and LDL cholesterol clearance methods
CH3810	0	-	For the quantitative in vitro determination of cholesterol in serum and plasma.
CH3811	0	-	An HDL-cholesterol test system is a device intended for the quantitative in vitro determination of HDL-cholesterol concentration in human serum and plasma.
CH3841	0	-	In Vitro device for the quantitative determination of LDL-Cholesterol in serum and plasma.
CK110	0	-	The device is intended for the quantitative in vitro determination of creatine kinase in serum or plasma.
CK113	0	-	The device is intended for the quantitative in vitro determination of creatine kinase in serum or plasma.
CK1212	0	-	The device is intended for use in the quality control of CK-MB assays on clinical chemistry systems.
CK1296	0	-	The device is intended for the quantitative in vitro determination of CK-MB concentration in serum or plasma.
CK1553	0	-	The device is intended for the quantitative in vitro determination of CK-MB concentration in serum or plasma.
CK2393	0	-	The device is intended for use in the calibration of CK-MB assays in clinical chemistry systems.
CK2813	0	-	The CK method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of creatine kinase activity in serum or plasma.
CK335	0	-	The device is intended for the quantitative in vitro determination of creatine kinase in serum or plasma.
CK3812	0	-	The device is intended for the quantitative in vitro determination of creatine kinase in serum or plasma.
CK3878	0	-	The device is intended for the quantitative in vitro determination of creatine kinase in serum or plasma.
CK522	0	-	The device is intended for the quantitative in vitro determination of creatine kinase in serum or plasma.
CK7947	0	-	The device is intended for the quantitative in vitro determination of creatine kinase activity in serum or plasma.
CM3845	0	-	A Complement C3 test system is a device intended for the quantitative in vitro determination of Complement C3 concentration in serum
CM3846	0	-	A Complement C4 test system is a device intended for the quantitative in vitro determination of Complement C4 concentration in serum
CP1423	0	-	The device is a latex agglutination slide test intended for qualitative and semi-quantitative in vitro diagnostic determination of C-Reactive Protein (CRP) concentration in serum.
CP2179	0	-	The device is intended for in vitro diagnostic use in the calibration of CRP assays on clinical chemistry systems.
CP2476	0	-	Randox High Sensitivity CRP Control Level I is a ready to use control in a stabilised protein base. It is intended for use with the Randox High Sensitivity CRP Assay (Catalogue No. CP3885) for the control of accuracy and the control of reproducibility.
CP2477	0	-	Randox High Sensitivity CRP Control Level II is a ready to use control in a stabilised protein base. It is intended for use with the Randox High Sensitivity CRP Assay (Catalogue No. CP3885) for the control of accuracy and the control of reproducibility.
CP2478	0	-	The device is intended for in vitro diagnostic use in the calibration of CRP assays on clinical chemistry systems.
CP2479	0	-	The device is intended for in vitro diagnostic use in the calibration of CRP assays on clinical chemistry systems.
CP2480	0	-	This product is intended for in vitro diagnostic use in the quality control of CRP on clinical chemistry systems.
CP2481	0	-	This product is intended for in vitro diagnostic use, in the quality control of CRP on clinical chemistry systems.
CP2499	0	-	The device is intended for in vitro diagnostic use in the calibration of CRP assays on clinical chemistry systems.
CP2572	0	-	The device is intended for the quantitative in vitro diagnostic determination of C-Reactive Protein (CRP) concentration in serum.
CP2714	0	-	The device is a latex agglutination slide test intended for qualitative and semi-quantitative in vitro diagnostic determination of C-Reactive Protein (CRP) concentration in serum.
CP2852	0	-	The XCRP method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of CRP in serum.
CP3826	0	-	The CRP test system is intended for the quantitative in vitro determination of CRP concentration in serum.
CP3847	0	-	The CRP test system is intended for the quantitative in vitro determination of C-Reactive Protein (CRP) concentration in serum or plasma.
CP3849	0	-	The CRP test system is intended for the quantitative in vitro determination of C-Reactive Protein (CRP) concentration in serum or plasma.
CP3850	0	-	The CRP test system is intended for the quantitative in vitro determination of C-Reactive Protein (CRP) concentration in serum or plasma.
CP3885	0	-	The CRP test system is intended for the quantitative in vitro determination of C-Reactive Protein (CRP) concentration in serum or plasma.
CP7949	0	-	The device is intended for the quantitative in vitro diagnostic determination of C-Reactive Protein (CRP) concentration in serum.
CP7950	0	-	The CRP test system is intended for the quantitative in vitro determination of CRP concentration in serum.
CP9742	0	-	The CRP test system is intended for the quantitative in vitro determination of CRP concentration in serum.
CQ3100	0	-	This product is intended for in vitro diagnostic use, in the quality control of Cardiac Markers on clinical chemistry and Immunoassay systems.
CQ3259	0	-	This product is intended for in vitro diagnostic use in the quality control of Cardiac Markers on clinical chemistry and Immunoassay systems.
CR2804	0	-	The CREA method used on the Dimension clinical chemistry system is an in vitro diagnostic device intended for the quantitative determination of Creatinine in serum, plasma or urine
CR3814	0	-	The is intended for the quantitative in vitro diagnostic determination of Creatinine in serum, plasma or urine

592 Results

Results Per Page

Catalog #

AvailableQty

Starting At

Name

Company Name

Description

CR3814

CREA

RANDOX LABORATORIES LIMITED

The is intended for the quantitative in vitro diagnostic determination of Creatinine in serum, plasma or urine

CR2804

CREA

RANDOX LABORATORIES LIMITED

The CREA method used on the Dimension clinical chemistry system is an in vitro diagnostic device intended for the quantitative determination of Creatinine in serum, plasma or urine

CQ3259

TRI-LEVEL CARDIAC CONTROL (CRD CONTROL 1, 2, 3)

RANDOX LABORATORIES LIMITED

This product is intended for in vitro diagnostic use in the quality control of Cardiac Markers on clinical chemistry and Immunoassay systems.

CQ3100

TRI-LEVEL CARDIAC CONTROL (CRD CONTROL 1, 2, 3)

RANDOX LABORATORIES LIMITED

This product is intended for in vitro diagnostic use, in the quality control of Cardiac Markers on clinical chemistry and Immunoassay systems.

CP9742

CRP

RANDOX LABORATORIES LIMITED

The CRP test system is intended for the quantitative in vitro determination of CRP concentration in serum.

CP7950

CRP

RANDOX LABORATORIES LIMITED

The CRP test system is intended for the quantitative in vitro determination of CRP concentration in serum.

CP7949

CRP

RANDOX LABORATORIES LIMITED

The device is intended for the quantitative in vitro diagnostic determination of C-Reactive Protein (CRP) concentration in serum.

CP3885

hsCRP

RANDOX LABORATORIES LIMITED

The CRP test system is intended for the quantitative in vitro determination of C-Reactive Protein (CRP) concentration in serum or plasma.

CP3850

frCRP

RANDOX LABORATORIES LIMITED

The CRP test system is intended for the quantitative in vitro determination of C-Reactive Protein (CRP) concentration in serum or plasma.

CP3849

frCRP

RANDOX LABORATORIES LIMITED

The CRP test system is intended for the quantitative in vitro determination of C-Reactive Protein (CRP) concentration in serum or plasma.

CP3847

frCRP

RANDOX LABORATORIES LIMITED

The CRP test system is intended for the quantitative in vitro determination of C-Reactive Protein (CRP) concentration in serum or plasma.

CP3826

CRP

RANDOX LABORATORIES LIMITED

The CRP test system is intended for the quantitative in vitro determination of CRP concentration in serum.

CP2852

CRP

RANDOX LABORATORIES LIMITED

The XCRP method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of CRP in serum.

CP2714

CRP

RANDOX LABORATORIES LIMITED

The device is a latex agglutination slide test intended for qualitative and semi-quantitative in vitro diagnostic determination of C-Reactive Protein (CRP) concentration in serum.

CP2572

CRP

RANDOX LABORATORIES LIMITED

The device is intended for the quantitative in vitro diagnostic determination of C-Reactive Protein (CRP) concentration in serum.

CP2499

CRP CAL

RANDOX LABORATORIES LIMITED

The device is intended for in vitro diagnostic use in the calibration of CRP assays on clinical chemistry systems.

CP2481

LIQUID CRP CONTROL - LEVEL 3 (CRP CONTROL 3)

RANDOX LABORATORIES LIMITED

This product is intended for in vitro diagnostic use, in the quality control of CRP on clinical chemistry systems.

CP2480

LIQUID CRP CONTROL - LEVEL 2 (CRP CONTROL 2)

RANDOX LABORATORIES LIMITED

This product is intended for in vitro diagnostic use in the quality control of CRP on clinical chemistry systems.

CP2479

CRP CAL

RANDOX LABORATORIES LIMITED

The device is intended for in vitro diagnostic use in the calibration of CRP assays on clinical chemistry systems.

CP2478

hsCRP CAL

RANDOX LABORATORIES LIMITED

The device is intended for in vitro diagnostic use in the calibration of CRP assays on clinical chemistry systems.

CP2477

HIGH SENSITIVITY CRP CONTROL - LEVEL II (hsCRP CONTROL 2)

RANDOX LABORATORIES LIMITED

Randox High Sensitivity CRP Control Level II is a ready to use control in a stabilised protein base. It is intended for use with the Randox High Sensitivity CRP Assay (Catalogue No. CP3885) for the control of accuracy and the control of reproducibility.

CP2476

HIGH SENSITIVITY CRP CONTROL - LEVEL I (hsCRP CONTROL 1)

RANDOX LABORATORIES LIMITED

Randox High Sensitivity CRP Control Level I is a ready to use control in a stabilised protein base. It is intended for use with the Randox High Sensitivity CRP Assay (Catalogue No. CP3885) for the control of accuracy and the control of reproducibility.

CP2179

CRP CAL

RANDOX LABORATORIES LIMITED

The device is intended for in vitro diagnostic use in the calibration of CRP assays on clinical chemistry systems.

CP1423

CRP

RANDOX LABORATORIES LIMITED

The device is a latex agglutination slide test intended for qualitative and semi-quantitative in vitro diagnostic determination of C-Reactive Protein (CRP) concentration in serum.

CM3846

RANDOX LABORATORIES LIMITED

A Complement C4 test system is a device intended for the quantitative in vitro determination of Complement C4 concentration in serum

CM3845

RANDOX LABORATORIES LIMITED

A Complement C3 test system is a device intended for the quantitative in vitro determination of Complement C3 concentration in serum

CK7947

CK-NAC

RANDOX LABORATORIES LIMITED

The device is intended for the quantitative in vitro determination of creatine kinase activity in serum or plasma.

CK522

CK NAC

RANDOX LABORATORIES LIMITED

The device is intended for the quantitative in vitro determination of creatine kinase in serum or plasma.

CK3878

CK NAC

RANDOX LABORATORIES LIMITED

The device is intended for the quantitative in vitro determination of creatine kinase in serum or plasma.

CK3812

CK NAC

RANDOX LABORATORIES LIMITED

The device is intended for the quantitative in vitro determination of creatine kinase in serum or plasma.

CK335

CK NAC

RANDOX LABORATORIES LIMITED

The device is intended for the quantitative in vitro determination of creatine kinase in serum or plasma.

CK2813

RANDOX LABORATORIES LIMITED

The CK method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of creatine kinase activity in serum or plasma.

CK2393

CK-MB CAL

RANDOX LABORATORIES LIMITED

The device is intended for use in the calibration of CK-MB assays in clinical chemistry systems.

CK1553

CK-MB

RANDOX LABORATORIES LIMITED

The device is intended for the quantitative in vitro determination of CK-MB concentration in serum or plasma.

CK1296

CK-MB

RANDOX LABORATORIES LIMITED

The device is intended for the quantitative in vitro determination of CK-MB concentration in serum or plasma.

CK1212

CK-MB CONTROL

RANDOX LABORATORIES LIMITED

The device is intended for use in the quality control of CK-MB assays on clinical chemistry systems.

CK113

CK NAC

RANDOX LABORATORIES LIMITED

The device is intended for the quantitative in vitro determination of creatine kinase in serum or plasma.

CK110

CK NAC

RANDOX LABORATORIES LIMITED

The device is intended for the quantitative in vitro determination of creatine kinase in serum or plasma.

CH3841

LDL

RANDOX LABORATORIES LIMITED

In Vitro device for the quantitative determination of LDL-Cholesterol in serum and plasma.

CH3811

HDL

RANDOX LABORATORIES LIMITED

An HDL-cholesterol test system is a device intended for the quantitative in vitro determination of HDL-cholesterol concentration in human serum and plasma.

CH3810

CHOL

RANDOX LABORATORIES LIMITED

For the quantitative in vitro determination of cholesterol in serum and plasma.

CH2673

D LDL/HDL CAL

RANDOX LABORATORIES LIMITED

The device is intended for in vitro diagnostic use in the calibration of Randox HDL and LDL cholesterol clearance methods

CH2655

DIRECT HDL-CHOLESTEROL (HDL)

RANDOX LABORATORIES LIMITED

Enzymatic Clearance assay for the in vitro quantitative determination of HDL-cholesterol in human serum and plasma.

CH203

HDL-CHOLESTEROL (HDL)

RANDOX LABORATORIES LIMITED

CH200

CHOLESTEROL (CHOL)

RANDOX LABORATORIES LIMITED

For the quantitative in vitro determination of Cholesterol in serum and plasma.

CF1501

CSF CONTROL - LEVEL 3 (CSF CONTROL 3)

RANDOX LABORATORIES LIMITED

This product is intended for in vitro diagnostic use, in the quality control of diagnostic methods using CSF as a sample on clinical chemistry systems. The CSF controls are for the control of accuracy.

CF1500

CSF CONTROL - LEVEL 2 (CSF CONTROL 2)

RANDOX LABORATORIES LIMITED

CE7944

BUTYRYL CHOLINESTERASE (CHE)

RANDOX LABORATORIES LIMITED

CE190

BUTYRYL CHOLINESTERASE (CHE)

RANDOX LABORATORIES LIMITED

CD7942

CO2

RANDOX LABORATORIES LIMITED

The device is intended for the quantitative in vitro determination of carbon dioxide in serum or plasma.